Gene282
ANCR: Angelman syndrome chromosome region
13 sourcesgene-search-2026-11-13-0.2.1
Cite this record
ConductScience Library. ANCR: Angelman syndrome chromosome region. Genes, record 282. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/282
Gene
NIH grants103
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ANCR papers | Newest fiscal year |
|---|---|---|---|
| T32CA009302 | Leveraging innovative technologies in basic and clinical cancer research | 3 | 2025 |
| R01AR045192 | REGULATORS OF EPIDERMAL GENE EXPRESSION | 2 | 2025 |
| P01CA013106 | Targeting Transcription and Splicing in Cancer | 1 | 2025 |
| P20GM109036 | Tulane COBRE for Clinical and Translational Research in Cardiometabolic Diseases | 1 | 2025 |
| P30CA045508 | CSHL Cancer Center Support Grant | 1 | 2025 |
| P41HD062499 | Gene Expression Database for Mouse Development | 1 | 2025 |
| P50CA127001 | SPORE in Brain Cancer | 1 | 2025 |
| R01AR041398 | Novel Molecular Biomarkers of Bone Microarchitecture | 1 | 2025 |
| R01AR049737 | Epidermal Signaling Regulators | 1 | 2025 |
| R01CA271915 | Targeting the BCL2 immune checkpoint to enhance the immunostimulatory effects of radiation in breast cancer | 1 | 2025 |
Source NIH's project files
Papers315
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exon junction complex and nuclear pore complex components preferentially govern the nuclear export of spliced lncRNAs. | Cell Death Discov | 2026 | 42420243 | PubTator, text mining | PubMed |
| Hyaluronic acid-functionalized Fe3O4 nanoparticles loaded with trans-chalcone: in vitro anticancer activity and lncRNA modulation in hepatocellular carcinoma cells. | Sci Rep | 2026 | 42401688 | PubTator, text mining | PubMed |
| Research on the Mechanism of "Cold Tumor" Formation and Immunotherapy for Its Transformation into "Hot Tumor". | Oncol Res | 2026 | 41799503 | PubTator, text mining | PubMed |
| Affine non-negative collaborative representation based pattern classification. | Complex Intell Systems | 2026 | 41788232 | PubTator, text mining | PubMed |
| Uremic Toxin-Driven Vascular Calcification in Chronic Kidney Disease: Molecular Pathways and Integrated Phenotypes. | Toxins (Basel) | 2026 | 41745778 | PubTator, text mining | PubMed |
| Harnessing Ribonucleoprotein Granule Biology for Cancer Therapy: The Central Role of Protein Modifications. | Research (Wash D C) | 2026 | 41716844 | PubTator, text mining | PubMed |
| Epigenetic regulation of cancer stemness. | Signal Transduct Target Ther | 2025 | 40744921 | PubTator, text mining | PubMed |
| Regulation and intervention of stem cell differentiation by long non-coding RNAs: Mechanisms and therapeutic potential. | World J Stem Cells | 2025 | 40740526 | PubTator, text mining | PubMed |
| Epigenetic control of dental stem cells: progress and prospects in multidirectional differentiation. | Epigenetics Chromatin | 2024 | 39623487 | PubTator, text mining | PubMed |
| METTL3-Mediated m6A Modification Regulates the Osteogenic Differentiation through LncRNA CUTALP in Periodontal Mesenchymal Stem Cells of Periodontitis Patients. | Stem Cells Int | 2024 | 38283119 | PubTator, text mining | PubMed |
None in this release
- Proteins
- Patents
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/282
GET https://conductscience.org/api/genes/v1/282/grants?page=2